Condition : Hearing Loss, Idiopathic Sudden Sensorineural
Interventions : Drug: AM-111 0.4 mg/ml; Drug: AM-111 0.8 mg/ml; Other: Placebo
Sponsor : Auris Medical, Inc.
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Wed, 22 Jun 2016 12:00:00 EDT
Last Update Posted: 08/07/20 06:52AM